Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium nitrite - Hope Pharmaceuticals

Next Previous
Search
Drug Profile

Sodium nitrite - Hope Pharmaceuticals

Alternative Names: Sodium nitrite injection - Hope Pharmaceuticals

Latest Information Update: 29 Sep 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hope Pharmaceuticals
  • Class Antidotes; Antihypertensives; Antivirals; Nitrites; Small molecules; Sodium compounds; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Haemoglobin modulators; Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Poisoning
  • No development reported Lung disorders; Myocardial infarction; Subarachnoid haemorrhage

Most Recent Events

  • 29 Sep 2022 No development reported - Phase-II for Lung disorders in USA (IV)
  • 15 Sep 2020 Hope Pharmaceuticals withdraws recruitment prior to enrolment in a phase-II trials in Lung disorders in USA (IV) (NCT04401527)
  • 07 Aug 2020 No development reported - Phase-II for Myocardial infarction in USA (IV) (Hope Pharmaceuticals pipeline, August 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top